International Biotechnology Trust plc
Share this pagePrint this page

Portfolio Analysis

30 June 2016

Summary

 

IBT Portfolio NAV (m)

202

Number of Portfolio Companies

86

Quoted Investments

60

Unquoted Investments

26

 

NAV % Quoted / Unquoted Split
NAV % by Geography

Quoted

89%

United States / Canada

77%

Unquoted

11%

Europe

23%

Total

100% 

Total

100%

 

 

 

 

 

NAV % by Therapeutic Areas
NAV % by Market Cap

 

 

Oncology

38%

Large Cap >USD10BN

68%

Orphan

20%

Mid Cap =USD1-10BN

6%

CNS

10%

Small Cap < USD1BN

26%

Inflammation

9%

 

 

 

Ophtalmology

8%

Medtech

5%

Other

10%

Total100%